In this track, we have modified CD4+ target cells with 2P23 peptide, antibody, or bispecific fusion proteins through glycosylphosphatidylinositol anchoring, which can render the cells fully resistant to HIV-1 infection (44, –, 47). The gene discussed is CD4; the disease is HIV-1 infection.